Skip to main content
. 2020 Dec 13;21(24):9486. doi: 10.3390/ijms21249486

Figure 6.

Figure 6

Taking advantage of oncogenic addiction in cancer with synthetic dosage lethality. (A) Myc produces target genes Aurora kinases A and B and CDK1, which help stabilize Myc and promote the cell cycle. MYC is commonly amplified in cancer and cells remain viable. (B) In MYC-overexpressing cancers, inhibiting CDK1 or Aurora kinases leads to cell cycle arrest and synthetic dosage lethality.